Status:
UNKNOWN
Latin-American Von Willebrand Disease Registry
Lead Sponsor:
Academia Nacional de Medicina
Conditions:
Von Willebrand Disease
Eligibility:
All Genders
Brief Summary
Establish a Latin-American network of centers and professionals with the aim of: * To register VWD patients in retrospective/prospective study, using a database, available online, common to all * To ...
Detailed Description
von Willebrand disease (VWD) is the most common autosomal bleeding disorder, mostly inherited as dominant trait. VWD is due to deficiency/abnormality of von Willebrand factor (VWF). The prevalence of ...
Eligibility Criteria
Inclusion
- Historically lowest VWF:Ag and/or VWF:RCo and/or VWF:CB \< 0.50 IU/ml and/or FVIII:C \< 0.50 IU/ml
- All types of VWD
- All ages
Exclusion
- Patient without consent to participate
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04279717
Start Date
February 1 2020
End Date
December 1 2022
Last Update
February 21 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.